Early research (Phase 1)Study completedNCT00053937
What this trial is testing
Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
Who this might be right for
Neurofibromatosis Type 1Precancerous Condition
National Cancer Institute (NCI)